Compliance-Certificate under Reg.74(5) of SEBI (DP) Regulation,2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma has submitted a routine quarterly compliance certificate from its Registrar and Transfer Agent, Bigshare Services Pvt. Ltd., for the quarter ended 30 June 2025. The certificate confirms that all securities received for dematerialization during the quarter were properly processed, listed on the stock exchange, and the depository's name was substituted as the registered owner within 15 days as required by SEBI rules. The filing was signed by Director Prakash Bhoorchand Shah (DIN: 01136800) and submitted to BSE on 18 July 2025. This is a standard regulatory compliance submission with no business transaction or financial event involved.
No material impact on shareholders or stock price. This is a routine procedural filing required under SEBI's depository regulations, confirming proper handling of dematerialization requests.